Bio-Techne (TECH) Change in Accured Expenses (2016 - 2026)
Bio-Techne has reported Change in Accured Expenses over the past 17 years, most recently at -$18.6 million for Q4 2025.
- For Q4 2025, Change in Accured Expenses fell 253.31% year-over-year to -$18.6 million; the TTM value through Dec 2025 reached -$38.5 million, down 446.68%, while the annual FY2025 figure was -$14.0 million, 210.59% down from the prior year.
- Change in Accured Expenses for Q4 2025 was -$18.6 million at Bio-Techne, down from -$2.1 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $13.9 million in Q1 2021 and troughed at -$26.0 million in Q2 2025.
- A 5-year average of $179650.0 and a median of $188500.0 in 2022 define the central range for Change in Accured Expenses.
- Biggest five-year swings in Change in Accured Expenses: soared 377.06% in 2021 and later crashed 575.63% in 2025.
- Year by year, Change in Accured Expenses stood at -$8.1 million in 2021, then fell by 25.11% to -$10.1 million in 2022, then surged by 179.65% to $8.1 million in 2023, then surged by 50.15% to $12.1 million in 2024, then tumbled by 253.31% to -$18.6 million in 2025.
- Business Quant data shows Change in Accured Expenses for TECH at -$18.6 million in Q4 2025, -$2.1 million in Q3 2025, and -$26.0 million in Q2 2025.